These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17947294)

  • 1. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic.
    Takahashi T; Kikuchi S; Katada S; Nagai Y; Nishizawa M; Onodera O
    Hum Mol Genet; 2008 Feb; 17(3):345-56. PubMed ID: 17947294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Oligomers of PolyQ-Expanded Huntingtin Target a Multiplicity of Key Cellular Factors.
    Kim YE; Hosp F; Frottin F; Ge H; Mann M; Hayer-Hartl M; Hartl FU
    Mol Cell; 2016 Sep; 63(6):951-64. PubMed ID: 27570076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and toxicity of soluble polyglutamine oligomers in living cells.
    Lajoie P; Snapp EL
    PLoS One; 2010 Dec; 5(12):e15245. PubMed ID: 21209946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1.
    Meriin AB; Mabuchi K; Gabai VL; Yaglom JA; Kazantsev A; Sherman MY
    J Cell Biol; 2001 May; 153(4):851-64. PubMed ID: 11352944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A toxic monomeric conformer of the polyglutamine protein.
    Nagai Y; Inui T; Popiel HA; Fujikake N; Hasegawa K; Urade Y; Goto Y; Naiki H; Toda T
    Nat Struct Mol Biol; 2007 Apr; 14(4):332-40. PubMed ID: 17369839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo.
    Legleiter J; Mitchell E; Lotz GP; Sapp E; Ng C; DiFiglia M; Thompson LM; Muchowski PJ
    J Biol Chem; 2010 May; 285(19):14777-90. PubMed ID: 20220138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence anisotropy uncovers changes in protein packing with inclusion growth in a cellular model of polyglutamine aggregation.
    Bhardwaj V; Panicker MM; Udgaonkar JB
    Biochemistry; 2014 Jun; 53(22):3621-36. PubMed ID: 24819723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion.
    Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM
    J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-precision FLIM-FRET in fixed and living cells reveals heterogeneity in a simple CFP-YFP fusion protein.
    Millington M; Grindlay GJ; Altenbach K; Neely RK; Kolch W; Bencina M; Read ND; Jones AC; Dryden DT; Magennis SW
    Biophys Chem; 2007 May; 127(3):155-64. PubMed ID: 17336446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
    Nozaki K; Onodera O; Takano H; Tsuji S
    Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis.
    King MA; Hands S; Hafiz F; Mizushima N; Tolkovsky AM; Wyttenbach A
    Mol Pharmacol; 2008 Apr; 73(4):1052-63. PubMed ID: 18199701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE).
    Prigge JR; Schmidt EE
    BMC Mol Biol; 2007 Sep; 8():76. PubMed ID: 17868456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting soluble polyQ oligomers and investigating their impact on living cells using split-GFP.
    Lajoie P; Snapp EL
    Methods Mol Biol; 2013; 1017():229-39. PubMed ID: 23719920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanism for spinocerebellar ataxias].
    Onodera O
    Rinsho Shinkeigaku; 2009 Jan; 49(1):1-8. PubMed ID: 19227889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-hairpin-mediated nucleation of polyglutamine amyloid formation.
    Kar K; Hoop CL; Drombosky KW; Baker MA; Kodali R; Arduini I; van der Wel PC; Horne WS; Wetzel R
    J Mol Biol; 2013 Apr; 425(7):1183-97. PubMed ID: 23353826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
    Verhoef LG; Lindsten K; Masucci MG; Dantuma NP
    Hum Mol Genet; 2002 Oct; 11(22):2689-700. PubMed ID: 12374759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
    Kaytor MD; Wilkinson KD; Warren ST
    J Neurochem; 2004 May; 89(4):962-73. PubMed ID: 15140195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin.
    Wang H; Lim PJ; Yin C; Rieckher M; Vogel BE; Monteiro MJ
    Hum Mol Genet; 2006 Mar; 15(6):1025-41. PubMed ID: 16461334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
    Hazeki N; Nakamura K; Goto J; Kanazawa I
    Biochem Biophys Res Commun; 1999 Mar; 256(2):361-6. PubMed ID: 10079189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
    Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.